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Renal insufficiencya b s t r a c t
Objectives: To evaluate the diagnostic accuracy of diffusion weighted MRI in diagnosis of
solid hepatic focal lesions in patients with impaired renal functions.
Patients and methods: This prospective study included (30) patients with impaired renal
function and had solid hepatic focal lesions based on ultrasound examination. All patients
subjected to diffusion MRI examination and ADC measurement, and the data obtained
were compared with histopathological results of malignant lesions and previously reported
appearance of benign lesions.
Results: There were 57 solid focal lesions in the included 30 patients. The mean ADC value
of hemangiomas was 2.03  103, lipoma was 0.1  103, HCC was 1.06  103 and for
metastases was 1.2  103. Benign lesions have significant higher ADC values than malig-
nant ones (p = 0.003), and in malignant lesions the primary hepatic carcinomas had lower
ADC values compared to metastatic lesions which had no significant value. Using a cutoff
value of 1.6  103 for the ADC to differentiate between benign and malignant lesions the
AUC was 90% with Sensitivity, Specificity, PPV, NPV and accuracy of 92%, 80%, 98%, 50% and
91% respectively.
Conclusion: DW-MRI and ADC value measurements are effective in characterizing solid
focal hepatic lesions without contrast injection in patients with renal impairment.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Management planning and treatment options of differ-
ent focal liver pathologies require an accurate detection
and characterization of these focal masses [1,2]. Imaging
of focal liver lesions by different imaging tools including
ultrasonography, computed tomography (CT) and mag-netic resonance imaging (MRI) is crucial, not only in the
diagnosis but also in the follow-up [3]. Precise localization,
measurement and numbering of focal liver lesions (FLLs)
are important to decide how to manage and how to follow
[1,2].
Due to its high tissue contrast resolution, lack of ioniz-
ing radiation and the capability of performing different
functional imaging sequences, and MR imaging of different
liver pathologies with and without IV contrast administra-
tion is of increasingly important role in evaluation of such
patients [4].
However, one of the most important limitations for giv-
ing IV contrast is renal complications [5]. Patients with
reduced renal function are at risk of developing contrast-
1266 H.N. Almassry et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1265–1274induced nephrotoxicity (CIN) following a contrast-
enhanced computed tomography examination with an iod-
inated contrast agent [1] and at risk of developing nephro-
genic systemic fibrosis (NSF) after a contrast-enhanced
MRI examination with an extracellular gadolinium-based
contrast agent [5,6].
Patients with estimated glomerular filtration rate
(eGFR) < 30 mL/min, including those on dialysis or waiting
for liver transplantation, should not receive nonionic linear
chelates. The lowest possible dose of stable Gd contrast
agents (macrocyclic chelates) should be used in these
patients [7]. Contrast-enhanced MRI examination should
be avoided whenever possible during pro-inflammatory
events, although hemodialysis shortly after Gd contrast
administration has not been shown to prevent NSF [8].
Consideration should be given to imaging techniques
that may offer the same diagnostic information without
needing to administer contrast materials [5,6].
With recent advances in technology, DW-MRI is reach-
ing a potential for clinical use in the abdomen, particularly
in the liver. DW MR imaging is an attractive technique for
multiple reasons: it can potentially add useful qualitative
and quantitative information to conventional imaging
sequences; it is quick (performed within a breath hold),
can be easily incorporated and is a non-enhanced tech-
nique (performed without the use of gadolinium-based
contrast media), thus easy to repeat, and useful in patients
with severe renal dysfunction at risk for developing
nephrogenic systemic fibrosis [9–11].
The aim of this study was to evaluate the diagnostic
accuracy of diffusion weighted MRI in diagnosis of solid
focal liver lesions in patients with impaired renal function.2. Patients and methods
This prospective study was carried out during the per-
iod from September 2014 to November 2015 and included
thirty patients with impaired renal function and had solid
focal liver lesions referred to Radiodiagnosis Department
from General Medicine, Oncology and Tropical Depart-
ments of Zagazig University Hospitals. They were 16 males
and 14 females, and their ages ranged from 28 to 70 years.
The study was approved by our institutional ethics
committees and a written consent was obtained from each
patient before participating in the study.2.1. Study design
During the study period thirty patients with impaired
renal function (eGFR < 30) and diagnosed to have solid
focal liver lesions based on ultrasound examination were
included in the study. Exclusion criteria were previous
intervention to the focal lesion as biopsy or chemo-
embolization, patients unfit for or having contraindication
to MRI examination. The included patients were subjected
to full clinical and laboratory evaluation, followed by MRI
examination.
Our study encountered 57 solid focal masses (15
patients had multiple lesions, one case of hemangioma, 4
cases of HCC and 10 cases of metastasis).Final diagnosis was based on histopathological exami-
nation in 26 patients. The remaining 4 cases (3 cases of
hemangioma and one case of lipoma) did not need biopsy
as they were diagnosed by their characteristic MRI findings
previously described in the literature [12,13].2.2. Protocol for liver MRI
Abdominal MR examination was performed using
1.5 tesla superconducting MR scanner (Intera Achiva Nova
Dual system, Philips Medical System, Best, the Nether-
lands) with abdominal coil in supine position as follows:
a. Conventional MRI was performed using the
following:
– Gradient echo T1 weighted images (WI) were
performed with the following parameters:
(TR = 4–5 ms, TE = 2 ms, 375  375 field of view
(FOV), 256  256 matrix, Flip angle(FA) = 10,
section thickness 5–7 mm), T1 in-phase and
out-of-phase (TR/TE, 110/5 ms; in-phase; out-
of-phase TR/TE, 110/2 ms; FA = 70; matrix,
256  256; slice thickness, 5–7 mm; FOV,
375  375).
– T2-weighted images (TR = 418 ms, TE = 80, Flip
angle = 90, 375  375 FOV, 256  256 matrix
and section thickness: 5–7 mm).
– Heavily T2WI (TR = 1095 ms, TE = 200, Flip
angle = 90, 375  375 FOV, 256  256 matrix
and section thickness: 5–7 mm).
– Axial STIR (Short time inversion recovery):
(TR = 418 ms, TE = 80, TI = 140 ms, FA = 90,
375  375 FOV, 256  256 matrix and section
thickness 5–7 mm).b. Diffusion weighted MR imaging (DW-MRI):
DW-MRI was obtained with a single-shot spin-
echoplanar sequence (TR/TE, 2800-3600/74, FA 90,
matrix: 128  128, section thickness 5–8 mm, intersection
gap 1 mm and FOV 380  380).
Two different b values (b = 0 and 1000 mm2/s) and
three directions were used.2.3. Image interpretation
All MRI images were transferred to workstation and
reviewed by a radiologist unaware about the clinical data
and ultrasonographic findings of the patients. The ADC
value of the described liver lesions was measured by plac-
ing the circular region of interest (ROI) as follows: the lar-
gest diameter of lesions was measured first; in large
lesions >1 cm three regions of interest (ROIs) were marked
off and measured in the same image and a mean value of SI
was acquired for ADC calculation; in smaller lesion 61 cm
one ROI was measured in its center; and for patients with
multiple lesions the ADC values of at least two lesions were
measured and an average ADC was included in the result.
In all lesions the regions of blood vessels, necrosis and arti-
facts were excluded during measurement.
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Histopathological examination was performed in 26
patients using fine needle aspiration in 23 patients (12
patients of HCC and 11 patients of metastases), and true
cut biopsy in 3 patients (2 patients of HCC and 1 patient
of metastases) both done using ultrasound guidance.
The primary site for metastatic lesions was breast can-
cer (n = 6), colorectal carcinoma (n = 4), renal cell carci-
noma (n = 1) and bronchial carcinoma (n = 1).2.5. Statistical analysis
ADC value of each lesion was compared with ADC of
normal hepatic parenchyma using Mann–Whitney and
paired t-tests. Data were expressed as mean (SD) unless
otherwise indicated and one way analysis of variance
(ANOVA) was used to compare the mean values between
the studied groups. For significant finding a post-ANOVA
pairwise comparison of mean was concluded and p value
<0.05 was considered significant. Also we use receiver
operating curve (ROC) to characterize benign and malig-
nant lesions. Validity of ADC for diagnosis of focal liver
lesions was tested by sensitivity, specificity, positive pre-
dictive value (PPV), negative predictive value (NPV) and
measure of agreement (Kappa test).3. Results
We included 30 patients with 57 solid focal liver
lesions, they were 16 males (63%) and 14 females (47%)
and their age ranged from 28 to 70 years with mean age
51.6 ± 11.5 years.
The final diagnosis of the 57 included masses was as fol-
lows: 52 (91%) malignant hepatic masses (18 HCC (32%)
and 34 (59%) metastasis), and 5 (9%) benign masses (4
(7%) hemangioma and one (2%) lipoma). Thirty-seven
(64%) of the 57 focal liver lesions were located in the right
lobe and 20 (36%) were in the left lobe. The diameter of the
lesions ranged between 5 and 157 mm with the mean size
of 21.6 ± 4 mm.
The mean ADC value for HCC was 1.06 ± 0.30 (range:
0.59  103 mm2/s and 1.5  103 mm2/s) (Fig. 1); for
metastasis the mean ADC value was 1.2 ± 0.57 (range:
0.5  103 mm2/s and 2.21  103 mm2/s) (Figs. 2 and 3);
for hemangiomas it was 2.03 ± 0.41 (range:
1.7  103 mm2/s and 2.5  103 mm2/s) (Fig. 4), (Table 1);
and the measured ADC value in the case of lipoma was
0.1  103 mm2/s (Fig. 5) (see Table 2).
There was an overlap in the ADC value between heman-
gioma and metastasis but the mean ADC value of metasta-
sis was significantly lower (p = 0.05); on the other hand
although an overlap was existed in the mean ADC value
between HCC and metastasis, the HCC was found to had
lower values; however, the difference was not significant
(p = 0.33).
Validity of ADC value for distinguishing benign and
malignant solid masses was evaluated using receiver oper-
ating curve (ROC), and we found that at ADC value of
1.6  103 mm2/s as a cutoff value the reported sensitivitywas 92%, a specificity of 80%, PPV of 98%, NPV of 50% and
accuracy of 91% (Table 3) (Fig. 6).4. Discussion
Planning strategy for Management of patients suffering
from solid focal liver lesions depends upon correct charac-
terization of these lesions as benign or malignant. Impor-
tance of the role of magnetic resonance imaging in the
evaluation of different liver pathologies is always increas-
ing owing to its high contrast resolution, and the possibil-
ity of performing functional imaging sequences [4].
Recently, intravenous gadolinium based contrast is
claimed to be responsible for developing NSF in patients
with renal insufficiency; hence, the need to develop novel
MRI techniques that do not require gadolinium becomes
insisting. DW-MRI is non-invasive, rapidly acquired, and
does not require administration of intravenous gadolin-
ium. This technique utilizes the measurement of thermally
induced random molecular motion in biological tissues,
known as Brownian motion [14].
The aim of this study was to evaluate the diagnostic
efficiency of DW-MRI in differentiating benign and malig-
nant solid focal liver lesions in patients with impaired
renal functions.
We included 30 patients with 57 solid hepatic focal
lesions. DW-MRI was performed for all patients with the
measurement of the ADC value of the masses, and the
results were compared and correlated with those of
histopathological results.
Appearances of focal liver lesions on DWI especially at
high b values were reported to be diagnostic in several
studies due to restricted diffusion and increased signal
intensity on DW images [15]. However, Abdel Latif et al.
[16] in their study stated that this measurement was a
qualitative assessment and represented a subjective
interpretation.
Also, the results of Parikh et al. [17] show improved
detection of malignant and benign FLLs by using DW imag-
ing compared with standard breath-hold T2-weighted
imaging, with equivalent performance of DW imaging
and T2-weighted imaging for lesion characterization.
In our study in accordance with the Abdel Latif et al.
[16] and Parikh et al. [17] benign and malignant solid hep-
atic masses show nearly the same pattern of appearance
with restricted diffusion and difficulty to discriminate the
nature of the lesion; as in hemangiomas appeared as well
defined hyperintense lesions, and on ADC map they
appeared isointense in three lesions (75%) and as hyperin-
tense with central hypointense area, and on ADC map
appeared as isointense with central area of hypointensity
in one lesion (25%). On the other hand twelve lesions
(66%) of HCC appeared as multiple hyperintense, and four
lesions (22%) appeared as mixed intensity of hyperintense
and isointense signal, and another two lesions (11%)
appeared as mixed intensity of hyperintense and hypoin-
tense signal, whereas on the ADC maps all the lesions were
of hypointense signal.
Metastatic lesions appeared as multiple hyperintense in
thirty-two (94%) lesions; two lesions (6%) displayed mixed
Fig. 1. MRimaging ofmulti-centricHCC in a 45 years oldpatient. (A)Axial T1GE reveals largehypointense focal lesionwith central areaofmarkedhypointensity
affectingmainly segment VIII, withmultiple hypointense satellites around it scattered all over the liver. (B) Axial T2 reveals large hyperintense focal lesionwith
central area ofmarkedhyperintensitywithmultiple hyperintense satellites around it. (C) Diffusionweighted echoplanar imagewith (b = 0) shows that the lesion
displays mixed hyperintense signal. (D) Diffusion weighted echoplanar image with (b = 1000) shows that the lesion remains hyperintense with central area of
hypointensity. (E) ADC map of the lesion reveals hypointensity. The lesion has ADC value of 1.52 103 mm2/s suggestive of malignant lesion.
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Fig. 2. MR imaging of metastatic renal cell carcinoma in a 60 years old patient. (A) Axial T1GE reveals multiple hypointense focal lesions in the Rt lobe of the
liver. (B) Axial T2 reveals multiple lesions of heterogenous hyperintensity. (C) Diffusion weighted echoplanar image with (b = 0) shows that the lesions show
mixed intensity of isointensity and hyperintensity mainly hyperintensity. (D) Diffusion weighted echoplanar image with b = 1000 shows that the lesions
show mixed hyperintensity. (E) ADC map of the lesion reveals hypointense signal. The lesion has low ADC value of 1.36  103 mm2/s suggestive of
malignant lesion.
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ADC maps all the lesions displayed hypointense signal.
ADC value was a measurable parameter of MRI diffu-
sion. There were various published studies confirming
the diagnostic usefulness of measuring ADC in the differen-
tiation of focal hepatic lesions. According to these studiesmalignant lesions had lower ADC values than benign
lesions which had been attributed to the higher cellularity
of malignant lesions [17,18].
In our study in accordance with previous studies we
found that there was a statistically significant difference
between the mean ADC value of the benign and malignant
Fig. 3. MR Imaging of metastatic cancer colon in a 60 years old patient. (A) Axial T1GE reveals multiple heterogenous hypointense focal lesions affecting the
whole liver. (B) Axial T2 reveals multiple hyperintense focal lesions with central areas of marked hyperintensity. (C) Diffusion weighted echoplanar image
with b = 1000 shows mixed intensity lesions of hypointensity and hyperintensity mainly hyperintensity. (D) ADC map of the lesion reveals hypointensity.
The lesion has high ADC value 2.1  103 mm2/s.
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the benign than malignant lesions measuring
2 ± 0.56  103 mm2 and 1.13 ± 0.45  103 mm2
respectively.
However Sandrasegaran et al. [19] and Miller et al. [20]
in their studies declared that the ADC values of solid
benign and malignant lesions were similar and DWI was
not valuable in distinguishing between benign and malig-
nant solid lesions.
The difference between mentioned studies may be due
to the use of variable b value as diffusion gradients in stud-
ies of Sandrasegaran et al. [19] and Miller et al. [20] and
they used small b values of 0 and 50.
In a study done by Sun et al. [21], they had evaluated
the characteristics of MR imaging of hepatic focal lesions
using ADC value and concluded that applying quantitative
analysis of liver lesions by measuring the ADC values
increases the accuracy in diagnosing these lesions.
In the study performed by Namimoto et al. [22], the
ADC values of hemangiomas were smaller than those of
cysts, owing to the high viscosity of the blood contents of
hemangiomas which also contain numerous interstitial
spaces, scars and hemorrhages restricting motion of
molecules.
Ichikawa et al. [23], in their study to differentiate
between the ADC value of hemangiomas, metastatic focal
lesions and hepatocellular carcinomas found that the hep-atic hemangiomas had shown higher ADC values than
those of hepatocellular carcinomas and metastases.
Different ADC values were reported for hemangioma in
the previous studies with measured value of
1.9  103 mm2/s in study of Gourtsoyianni et al. [24]
and the mean was 2.22  103 ± 0.45 and
1.72  103 ± 0.30 in studies of Kandpal et al. [25] and
Oner et al. [26] respectively.
In this study the mean ADC value of hemangiomas was
in the same range as in previous studies measuring
2.03  103 ± 0.4 and ranged between 1.7  103 mm2/s
and 2.5  103 mm2/s.
Also different ADC values were described for HCC and
metastasis in previous reports; in the study of Gourt-
soyianni et al. [24], the ADC value of HCC was
1.38  103 mm2/s and ADC value reported by Sun et al.
[27] was 0.91  103 mm2/s, while mean ADC value
reported by Kandpal et al. [25] was 1.22  103 ± 0.34.
In accordance with these reports in our study the mean
ADC of HCC was 1.06  103 ± 0.30, ranged between
0.59  103 mm2/s and 1.5  103 mm2/s.
For ADC value of metastasis also different figures were
encountered in the literature; in the study of Gourt-
soyianni et al. [24], mean ADC value of metastases was
0.99  103 ± 0.22, while that reported by Kandpal et al.
[25] was 1.06  103 ± 0.36; however, ADC value reported
by Sun et al. [27] was 1.13  103 mm2/s.
Fig. 4. MR imaging of hemangioma in a 41 years old patient. (A) Axial T1GE shows well defined hypointense lesion with central area of marked
hypointensity in segments IV and VIII. (B) Axial T2WI reveals hyperintensity of the lesion with area of marked hyperintensity. (C) Diffusion weighted echo
planar image with b = 0 shows marked homogenous hyperintense lesion. (D) Diffusion weighted echo planar image with b = 1000 shows hyperintense
signal with central hypointense area. (E) ADC map of the lesion reveals isointense lesion with central area of hypointensity. The lesion has high ADC value of
1.9  103 mm2/s suggestive of benign lesion.
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where the mean ADC at the metastatic lesions was
1.2  103 ± 0.57 and ranged between 0.5  103 mm2/s
and 2.17  103 mm2/s.
Comparing the ADC value between solid malignant
lesions we found that the ADC value of HCC somewhatwas less than that of metastatic lesions, and this was in
coincidence with Namimoto et al. [22].
From previous results we had emphasized that the
presence of different ADC values for different lesions was
attributed to the size of the lesion, localization of the ROI
within the lesions, presence of areas of necrosis or hemor-
Table 1
Mean and range of ADC values of included liver lesions.
Pathology (57 masses) ADC value
Mean Range
Hemangioma 2.03 ± 0.41  103 mm2/s 1.7  103–2.5  103 mm2/s
HCC 1.06 ± 0.30  103 mm2/s 0.59  103–1.5  103 mm2/s
Metastases 1.2 ± 0.57  103 mm2/s 0.5  103–2.21  103 mm2/s
Fig. 5. MR imaging of lipoma in a 62 years old patient. (A) Axial T1GE reveals well defined hyperintense focal lesion in segment IV of Lt lobe. (B) Axial T2
reveals well defined less hyperintense lesion in segment IV of Lt lobe and another two small lesions in segment VII of the Rt lobe. (C) Axial STIR reveals
hypointense focal lesion. (D) Diffusion weighted echo planar image with b = 0 shows that the lesion shows signal void. (E) Diffusion weighted echo planar
image with b = 1000 shows that the lesion maintains signal void. (F) ADC map of the lesion reveals signal void. ADC value of the lesion is low
0.1  103 mm2/s.
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Table 2
Overall mean ADC value of benign and malignant masses.
Benign (n = 4) Malignant (n = 26) MW p
At lesion ADC: (103 mm2/s)




Validity of ADC in differentiating malignant and benign focal hepatic
lesions.
Cutoff AUC Sens. Spec. PPV NPV Accuracy p-value
61.6 0.90 92 80 98 50 91 <0.001⁄⁄
** Highly significant.
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these variations the overall ADC value for solid benign
masses was higher than that of solid malignant masses
and was statistically significant in our study (p = 0003).
In this study there was overlap between ADC value of
hemangiomas ranged between 1.7  103 mm2/s and
2.5  103 mm2/s and metastases having ADC value ran-
ged between 0.5  103 mm2/s and 2.17  103 mm2/s
and such overlap may be due to necrosis and hemorrhage
in some cases of metastatic lesions.
Also Bruegel et al. [28], in their study found that the
ADC values of metastases and hemangiomas were signifi-
cantly different regarding their means; however, they
showed overlap to some extent.
The diffusion capacity of fat is reported to be low lead-
ing to decreased ADC values. Reported values are 0.15–
0.59  103 mm2/s, which are considerably lower com-
pared to other benign tissues. A possible explanation for
this finding is that MR signals come primarily from lipidFig. 6. Receiver operating characteristic curves for ADC value for diffebound water protons, which have conceivably a more
restricted mobility than unbound protons. In addition
large, slowly diffusing triglyceride molecules have a low
diffusion capacity, which also results in low ADC values
[29–31].
In this study we had one case of lipoma revealed signal
void on both DWI and ADC maps, its ADC value measures
0.1  103 mm2/s, and it was similar to that of malignant
lesions, but lipoma can be easily differentiated depending
on its signal appearance on different MRI sequences.
Previous studies reported variable ADC cutoff values for
discrimination between malignant and benign hepatic
focal lesions. Abdel Latif et al. [16], in their study used
1.0  103 mm2/s as an ADC cutoff value at b 1000 resulted
in 90.3% sensitivity, 78.6% specificity and 86.7% accuracy
and they stated that the preferable results were obtained
with ADC cutoff value of 1.5  103 mm2/s (at b 500) and
1.0  103 mm2/s ADC cutoff value (at b 1000), with
90.3% sensitivity, 92.86% specificity, and 91.1% accuracy.
Taouli et al. [18] use a cutoff value of 1.5  103 mm2/s
at b 500 and they record a sensitivity of 84% and specificity
of 89%. Parikh et al. [8] in their study reported
1.6  103 mm2/s as a cutoff value at b 500 gradient and
had sensitivity of 74.2% and specificity of 77.3%. And Onur
et al. [32] stated a cutoff value of 1.23  103 mm2/s at b
1000 with sensitivity of 83% and specificity of 76% for dif-
ferentiation between benign and malignant lesions.rentiation between malignant and benign solid hepatic masses.
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vious studies when we used an ADC value of
1.6  103 mm2/s as cutoff value at b 1000 that results in
92% sensitivity, 80% specificity, 98% PPV, 50% NPV and
91% accuracy with AUC 0.90.
We had several limitations in our study as small num-
ber of the lesions were in each group especially in the
benign lesions; we had only two benign entities: heman-
gioma and lipoma; and also IV contrast could not be used
due to the impaired renal functions of patients included
in our study.
5. Conclusion
From this study we concluded that the use of contrast
materials is no longer needed in characterization of solid
focal liver lesions, especially in patients with impaired
renal functions, as DW-MRI and ADC value measurements
are proved to be effective techniques with high sensitivity
and accuracy in characterizing these lesions.
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